Search Results - "de Weger, R.A"

Current technologies for HER2 testing in breast cancer by Moelans, C.B, de Weger, R.A, Van der Wall, E, van Diest, P.J

“…Abstract Background Molecular techniques play an increasingly important role in breast cancer detection and help in the prediction of prognosis and treatment…”
Get full text

Continuous-Flow Left Ventricular Assist Device Support is Associated with Aortic Valve Interstitial Cell Activation by van Rijswijk, J.W, Martina, J.R, de Jonge, N, de Weger, R.A, Vink, A, Kluin, J

Get full text

Characterization of Lymphoid Clusters in the Transplanted Heart; an Effort To Form Tertiary Lymphoid Clusters? by Huibers, M.M, Gareau, A, Lee, T.D, Kruit, R, Feringa, H, Siera-de Koning, E, de Jonge, N, de Weger, R.A

Get full text

Localization of microRNAs in Cardiac Allograft Vasculopathy With In Situ Hybridization; a Role in Immune Regulation and/or Fibrosis? by Huibers, M.M, van Holthe tot Echten, B, Peeters, T, de Jonge, N, Tellides, G, de Weger, R.A

Get full text

The Amount of Autophagy-Related Cardiomyocyte Cell Death Is Associated With the Type of Pathogenic Mutation in Genetic Dilated Cardiomyopathy by van der Klooster, Z.J, Sepehrkhouy, S, Harakalova, M, Goldschmeding, R, de Jonge, N, Suurmeijer, A.J, de Weger, R.A, Asselbergs, F.W, Vink, A

Get full text

The Role of Loss-of-Function Mutations on Death and Development of Rejection in HTX/LTX Patients by van Setten, J, de Jonge, N, Holmes, M.V, Khush, K.K, Sweitzer, N.K, Garcia-Pavia, P, Rossano, J.W, Dries, D.L, Potena, L, Zuckermann, A, Christie, J.D, Wilkes, D.S, Lederer, D, Meyer, K.C, Glanville, A.R, Corris, P, Fisher, A, Palmer, S.M, Belperio, J.A, de Weger, R.A, Otten, H.G, van de Graaf, E.A, Keating, B, Asselbergs, F.W

Get full text

Changes of Plasma microRNAs in Heart Transplantation Patients Do Not Reflect microRNA Changes in the Cardiac Allograft Vasculopathy Vessel Wall by Huibers, M.M.H, Vroman, H, van Kuik, J, Siera-de Koning, E, de Jonge, N, de Weger, R.A

“…Purpose A limiting factor for long term survival after heart transplantation (HTx) is cardiac allograft vasculopathy (CAV). CAV is characterized by hyperplasia…”
Get full text

76 Thrombus Formation at the Pump Inflow Area in Heart Mate II Patients by Schipper, M.E.I, Vink, A, Dullens, H.F.J, de Weger, R.A, de Jonge, N, Lahpor, J.R

Get full text

Long-Term Survival after Heart Transplantation Depends on Proper Outward Remodeling of Epicardial Arteries with Cardiac Allograft Vasculopathy by Huibers, M.M.H, Kaldeway, J, Huisman, A, Timmermans, K, Leenders, M.B, Schippers, M.E.I, Vink, A, Lahpor, J.R, Kirkels, H.J.H, Klöpping, C, de Jonge, N, de Weger, R.A

“…Purpose Long term survival after heart transplantation (HTx) is hampered by chronic rejection. The immune reaction in the coronary arteries leads to Cardiac…”
Get full text

Post-Transcriptional Regulation of alpha-1-Antichymotrypsin by miR-137 in Chronic Heart Failure and Mechanical Support by Lok, S.I, van Mil, A, Bovenschen, N, van der Weide, P, van Kuik, J, van Wichen, D.F, Peeters, T, Siera, E, Winkens, B, Sluijter, J.P.G, Doevendans, P.A.F, da Costa Martins, P.A, de Jonge, N, de Weger, R.A

“…Purpose Better understanding of remodeling is a major objective of heart failure (HF) research to stop/reverse its progression. Left ventricular assist devices…”
Get full text

350: Osteopontin mRNA as a Biomarker for Heart Failure after Left Ventricular Assist Device Support and Heart Transplantation by Schipper, M.E.I, Scheenstra, M.R, van Kuik, J, van Wichen, D.F, van der Weide, P, de Jonge, N, de Weger, R.A

Get full text

459: Altered Micro-RNA Expression in the Heart after LVAD Support by Dullens, H.F.J, van Kuik, J, Schipper, M.E.I, de Jonge, N, de Weger, R.A

Get full text

183: The Role of Cathepsin K in Extra Cellular Matrix Remodeling in Patients with End Stage Heart Failure by van der Weide, P, Bruggink, A.H, van Wichen, D.F, van Kuik, J, de Jonge, N, Lahpor, J.R, Schipper, M.E.I, de weger, R.A

Get full text

546: Localization and Distribution of Micro-RNAs in the Myocardium of Heart Failure Patients before and after LVAD Support by Van Kuik, J, Lok, S, Schipper, M.E.I, Dullens, H, De Windt, L, Da Costa Martins, P.A, De Jonge, N, de Weger, R.A

Get full text

TNFα in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device by Bruggink, A.H, van Oosterhout, M.F.M, De Jonge, N, Gmelig-Meyling, F.H.J, De Weger, R.A

“…Abstract Background In the heart elevated levels of TNFα can cause lethal heart failure, like Dilated Cardiomyopathy (DCM). The level of TNFα production is in…”
Get full text

33: T-Cells Producing Both IFN-γ and TGF-β Induce Cardiac Allograft Vasculopathy by van Kuik, J, van Wichen, D.F, Siera-de Koning, E, de Jonge, N, Dullens, H.F.J, Gmelig-Meyling, F.H.J, de Weger, R.A

Get full text

61: Changes in the Protein Profiles of the Human Failing Heart after Left Ventricular Assist Device (LVAD) Support by van der Weide, P, Bovenschen, N, Siera-de Koning, E, van Kuik, J, Schipper, M.E.I, de Jonge, N, de Weger, R.A

Get full text

374: Altered Expression of Genes Involved in Mechanotransduction and Fibrosis after Mechanical Support of Failing Hearts by van Kuik, J, van Oosterhout, M.F.M, Siera de Koning, E, de Jonge, N, de Weger, R.A

Get full text

195: Integrin Profile Changes after Left Ventricular Assist Device Support by van Kuik, J, van Oosterhout, M.F.M, Sohns, W, Siera, E, van Wichen, D.F, de Jonge, N, Schipper, M.E.I, de Weger, R.A

Get full text

375: Proteomic Profiling of the Human Heart Following Left Ventricular Assist Device Support by van der Weide, P, Bovenschen, N, Siera- de Koning, E, van Kuik, J, van Oosterhout, M.F.M, Schipper, M.E.I, de Jonge, N, de Weger, R.A

Get full text